EuBiologics Co., Ltd. (206650.KQ)
KRW 11230.0
(0.99%)
KRW 11230.0
(0.99%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 67.82 Billion KRW | 17.89% |
| 2022 | 57.53 Billion KRW | 73.42% |
| 2021 | 33.17 Billion KRW | -43.85% |
| 2020 | 59.07 Billion KRW | 2.19% |
| 2019 | 57.81 Billion KRW | 35.42% |
| 2018 | 42.69 Billion KRW | 390.7% |
| 2017 | 8.7 Billion KRW | -13.82% |
| 2016 | 10.09 Billion KRW | -60.81% |
| 2015 | 25.76 Billion KRW | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 46.65 Billion KRW | -31.21% |
| 2024 Q2 | 45.41 Billion KRW | -2.66% |
| 2023 Q2 | 46.03 Billion KRW | 9.9% |
| 2023 Q3 | 46.61 Billion KRW | 1.28% |
| 2023 Q4 | 67.82 Billion KRW | 45.49% |
| 2023 Q1 | 41.88 Billion KRW | -27.19% |
| 2023 FY | 67.82 Billion KRW | 17.89% |
| 2022 Q2 | 39.42 Billion KRW | 1.93% |
| 2022 FY | 57.53 Billion KRW | 73.42% |
| 2022 Q4 | 57.53 Billion KRW | 50.93% |
| 2022 Q3 | 38.11 Billion KRW | -3.32% |
| 2022 Q1 | 38.68 Billion KRW | 16.61% |
| 2021 FY | 33.17 Billion KRW | -43.85% |
| 2021 Q3 | 37.52 Billion KRW | -56.38% |
| 2021 Q2 | 86.02 Billion KRW | 46.59% |
| 2021 Q4 | 33.17 Billion KRW | -11.59% |
| 2021 Q1 | 58.68 Billion KRW | 0.0% |
| 2020 FY | 59.07 Billion KRW | 2.19% |
| 2019 FY | 57.81 Billion KRW | 35.42% |
| 2018 FY | 42.69 Billion KRW | 390.7% |
| 2017 FY | 8.7 Billion KRW | -13.82% |
| 2016 FY | 10.09 Billion KRW | -60.81% |
| 2015 FY | 25.76 Billion KRW | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 53.19 Billion KRW | -27.493% |
| CMG Pharmaceutical Co., Ltd. | 40.02 Billion KRW | -69.434% |
| Celltrion Pharm, Inc. | 264.97 Billion KRW | 74.404% |
| Huons Global Co., Ltd. | 407.28 Billion KRW | 83.347% |
| DongKook Pharmaceutical Co., Ltd. | 263.36 Billion KRW | 74.247% |
| Enzychem Lifesciences Corporation | 16.91 Billion KRW | -300.879% |
| Humedix Co., Ltd. | 21.91 Billion KRW | -209.493% |
| Boditech Med Inc. | 30.48 Billion KRW | -122.483% |
| FutureChem Co.,Ltd | 8.91 Billion KRW | -660.463% |
| Huons Co., Ltd. | 206.87 Billion KRW | 67.215% |
| BNC Korea Co., Ltd. | 21.94 Billion KRW | -209.051% |
| AptaBio Therapeutics Inc. | 38.19 Billion KRW | -77.588% |